Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Niemann-Pick disease type C
(
NPC
) is characterized by progressive neurodegeneration and arises from mutations in the
NPC1
gene. Cholesterol has received most attention in the pathogenesis of
NPC
, but normalizing lipid levels in humans or mouse does not prevent neurodegeneration. In
NPC
mouse, neuronal degeneration in the cerebellum is the most commonly detected change, and thus previous studies have tended to focus on the cerebellum, especially Purkinje cells. Although numerous peptides have been found in the mammalian central nervous system, little data on neurotransmitters in
NPC
are available, and information on neurotransmitter system abnormalities could explain the complex and characteristic deficits of
NPC
. Thus, we performed an immunohistochemical study on
NPC
mouse cortices to compare cell numbers exhibiting vasoactive intestinal polypeptide (VIP), neuropeptide Y (NPY), and
substance P
(SP) immunoreactivity. In terms of VIP and NPY-immunoreactive (ir) cell numbers in the cerebral cortex, SP-ir cells were significantly reduced by about 90% in
NPC
(-/-) versus
NPC
(+/+) mouse, and were also mildly decreased in frontal and parietal
NPC
(+/-) versus
NPC
(+/+) mouse cortex. This study demonstrates for the first time, reduced number of SP-ir cells in the
NPC
mouse cortex.
...
PMID:Substance P immunoreactive cell reductions in cerebral cortex of Niemann-Pick disease type C mouse. 1586 36
To understand the interactions between
substance P
and gut inflammation, changes in
substance P
levels were evaluated in a chronic model of ileitis in response to three anti-inflammatory agents with distinct mechanisms of action. The agents were the prostaglandin E(1) analogue misoprostol (30 mug/kg, s.c., b.i.d.), the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 100 mug/ml in drinking water) and the leumedin, N-(fluorenyl-9-methoxycarbonyl)-L-leucine (
NPC
15199, 10 mg/kg, s.c.). Ileitis was induced by a transmural injection of trinitrobenzene sulphonic acid (TNBS 30 mg/kg in 50% ethanol) into the distal ileum of guinea-pigs. All anti-inflammatory therapies were introduced after TNBS administration and continued until day 7, when guinea-pigs were killed. Ileal
substance P
levels were measured by radioimmunoassay, and granulocyte infiltration was quantified by myeloperoxidase (MPO) activity. Protein and nitrite (an index of nitric oxide formation) levels in a luminal saline lavage were quantified in all groups. TNBS ileitis caused a marked reduction in ileal
substance P
content and increased MPO activity, protein and nitrite secretion. The nitric oxide synthase inhibitor, L-NAME, completely restored all parameters to baseline. Misoprostol attenuated the granulocyte infiltration and exacerbated protein leak but had no effect on
substance P
levels. In contrast,
NPC
15199 had no effect on granulocyte infiltration but normalized
substance P
levels and protein leak. Only L-NAME and
NPC
15199 blocked the TNBS induced increase in nitrite levels. These results suggest that the regulation of granulocyte infiltration in this model is unrelated to changes in
substance P
levels. Inhibition of nitric oxide synthase was the most effective therapeutic strategy in TNBS ileitis but the precise interactions between nitric oxide and the enteric nervous system during inflammatory states remain to be defined.
...
PMID:Anti-inflammatory agents and substance P depletion in experimental ileitis. 1847 36
<< Previous
1
2